• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake.

作者信息

Loogen F, Worth H, Schwan G, Goeckenjan G, Lösse B, Horstkotte D

出版信息

Cor Vasa. 1985;27(2-3):111-24.

PMID:4028729
Abstract

Over a period of up to 18 years, 24 patients (mean age: 33.8 years) with primary vascular pulmonary hypertension (PVPH) of unknown aetiology (group A) and 18 subjects (mean age: 45.3 years) with PVPH due to anorectic drug intake (group B) were comparatively studied. The following main tendencies became apparent: 1) The 10-year cumulative survival rate in group A (0.31) was lower than in group B (0.63). 2) Patients of group A showed more marked X-ray and ECG signs of pulmonary hypertension and right ventricular hypertrophy in comparison with group B. In contrast to group B, the ECG signs of hypertrophy in group A increased during the observation period. 3) Mean pulmonary artery pressure (PAP) significantly increased in group A (from 48.8 to 61.0 mmHg), while it decreased (from 47.6 to 33.3 mmHg) in group B. 4) The diameter of the descending branch of the right pulmonary artery increased with rising PAP only in group A, while the relationship between PAP and the Sokolow-Lyon index was significant only for the whole group of PVPH patients but not for the subgroups A and B. A regression of pulmonary hypertension in patients with anorectic drug intake was obvious, in contrast to the course in patients with PVPH of unknown aetiology.

摘要

相似文献

1
Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake.
Cor Vasa. 1985;27(2-3):111-24.
2
[Long-term course of primary vascular pulmonary hypertension with and without intake of appetite depressants].[有无服用食欲抑制剂情况下的原发性血管性肺动脉高压的长期病程]
Z Kardiol. 1983 Apr;72(4):215-21.
3
Aminorex and pulmonary hypertension. A review.氨苯恶唑与肺动脉高压。综述
Cor Vasa. 1985;27(2-3):160-71.
4
Primary pulmonary hypertension: follow-up of patients with and without anorectic drug intake.
Cor Vasa. 1980;22(4):251-7.
5
Development of pulmonary aneurysm in primary pulmonary hypertension: a case report.原发性肺动脉高压合并肺动脉瘤的病例报告
Angiology. 1986 Apr;37(4):319-24. doi: 10.1177/000331978603700409.
6
[Chronic pulmonary hypertension of vascular origin, plexogenic pulmonary arteriopathy and the appetite depressant aminorex: addenda to an epidemic].[血管源性慢性肺动脉高压、丛状肺血管病与食欲抑制剂阿米雷司:一种流行病的补遗]
Schweiz Med Wochenschr. 1985 Jun 8;115(23):782-9contd.
7
[Drug-induced primary vascular pulmonary hypertension. Contribution to its etiology and clinical course].[药物性原发性血管性肺动脉高压。对其病因和临床病程的贡献]
Med Welt. 1976 Jun 25;27(26):1300-3.
8
The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension.
Chest. 1997 Sep;112(3):714-21. doi: 10.1378/chest.112.3.714.
9
Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?肺动脉高压、“丛状肺血管病”与食欲抑制剂氨基苯唑:因果孰先孰后?
Bull Eur Physiopathol Respir. 1979 Sep-Oct;15(5):897-923.
10
[Thrombocyte behavior in patients with "primary" pulmonary hypertension. Pathogenesis of aminorex-induced pulmonary hypertension].
Acta Med Austriaca Suppl. 1980;19:1-28.

引用本文的文献

1
Dasatinib-induced pulmonary arterial hypertension.达沙替尼致肺动脉高压。
Br J Clin Pharmacol. 2018 May;84(5):835-845. doi: 10.1111/bcp.13508. Epub 2018 Mar 6.
2
Epidemiology of pulmonary arterial hypertension.肺动脉高压的流行病学。
Curr Hypertens Rep. 2013 Dec;15(6):638-49. doi: 10.1007/s11906-013-0397-5.
3
Drug-induced pulmonary arterial hypertension: a recent outbreak.药物性肺动脉高压:最近的一次爆发。
Eur Respir Rev. 2013 Sep 1;22(129):244-50. doi: 10.1183/09059180.00003313.
4
Safety of drug therapies used for weight loss and treatment of obesity.用于减肥和肥胖症治疗的药物疗法的安全性。
Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001.
5
Appetite suppressants and primary pulmonary hypertension in the United Kingdom.英国的食欲抑制剂与原发性肺动脉高压
Br Heart J. 1995 Dec;74(6):660-3. doi: 10.1136/hrt.74.6.660.
6
Primary pulmonary hypertension and fenfluramine use.原发性肺动脉高压与芬氟拉明的使用
Br Heart J. 1993 Dec;70(6):537-41. doi: 10.1136/hrt.70.6.537.